Law Series 11 Aug 2017 Anti-Activist Poison Pills Marcel Kahan Edward Rock Activism Hedge Funds Poison Pill Shareholders
Finance Series 02 Aug 2017 How Valuable are Independent Directors? Evidence from External Distractions Ronald Masulis Emma Jincheng Zhang Boards Independent Directors
Finance Series 05 Sep 2017 Are Investors Aware of Ownership Connections? Edith Ginglinger Camille Hebert Luc Renneboog Business Groups Common Ownership Ownership
Law Series 08 Sep 2017 The Dialogue between the Chairman of the Board and Investors: The Practice in the UK, the Netherlands and Germany and the Future of the German Corporate Governance Code Under the New Chairman Klaus Hopt Boards Institutional Investors
Finance Series 27 Aug 2017 What Makes the Bonding Stick? A Natural Experiment Testing the Legal Bonding Hypothesis Amir Licht Christopher Poliquin Jordan Siegel And more (...) Cross-listing Reputation
Finance Series 27 Sep 2017 Shareholder Conflicts and Dividends Janis Berzins Øyvind Bøhren Bogdan Stacescu Agency Dividends Shareholders
Law Series 15 Oct 2017 Corporate Scandals and Regulation Luzi Hail Ahmed Tahoun Clare Wang Accounting Regulation
Law Series 18 Sep 2017 The Promise and Perils of Crowdfunding: Between Corporate Finance and Consumer Contracts John Armour Luca Enriques Capital Crowdfunding Innovation
Law Series 25 Sep 2017 Fintech and the Financing of Entrepreneurs: From Crowdfunding to Marketplace Lending Mark Fenwick Joseph McCahery Erik Vermeulen Banking Capital Crowdfunding Innovation
Law Series 25 Sep 2017 Good Activist/Bad Activist: The Rise of International Stewardship Codes Jennifer Hill Institutional Investors Shareholders Stewardship
Finance Series 28 Oct 2017 The Long-Term Consequences of Short-Term Incentives Alex Edmans Vivian W. Fang Allen H. Huang Incentives Short-termism
